Download
accelerating oncology clinical development in asia n.
Skip this Video
Loading SlideShow in 5 Seconds..
Accelerating Oncology Clinical Development in Asia PowerPoint Presentation
Download Presentation
Accelerating Oncology Clinical Development in Asia

Accelerating Oncology Clinical Development in Asia

885 Vues Download Presentation
Télécharger la présentation

Accelerating Oncology Clinical Development in Asia

- - - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

  1. Accelerating Oncology Clinical Development in Asia Pharma Trials Asia 2010, Singapore 18th March Dr. Ross Horsburgh, VP Asia/Pacific, Kendle International

  2. What’s happened so far Prehistory AsiaDifferent AsiaBig AsiaGlobal Pre 1990 Ad-hoc Investigator-interest trials Early 90’s Asia specific diseases or questions Late 90’s Large scale trials Rescue studies NOW Inclusion in global development

  3. Oncology already a key area for Asia

  4. IRESSA still a great case study for Asia ISEL trial: -5 Asian markets (Taiwan, Thailand, Singapore, Malaysia, Philippines) - 342 Asian patients of total 1692 globally Overall no difference in survival Iressa vs. placebo However pre-planned sub-group analysis of Asian patient cohort showed significant benefit

  5. Oncology DD in Asia was metrics-driven

  6. Oncology now full spectrum in Asia

  7. The questions have evolved Prehistory AsiaDifferent AsiaBig AsiaGlobal Should we? Do what? How toBuild? How tooptimise? 7

  8. Asia’s important differences Large population Lower costs (espec. Procedures) Fast execution Focus on science & education Lack of legacy systems / mindset Rapid growth High rate of change(sites / personnel / CRO’s / newco’s / regulations)

  9. Ensure you think “strategic opportunities” not “operational issues” No unique operational challenges Asia wont follow EU / USA “if it looks like they did is it the best approach?” Winners will best exploit the differences Asia’s greatest contribution will be innovation - process - science / products

  10. (1) Drive Efficiencies Large population Lower costs (espec. Procedures) Fast execution Focus on science & education Lack of legacy systems / mindset Rapid growth High rate of change(sites / personnel / CRO’s / newco’s / regulations) 10

  11. (2) Leverage the science & innovation Large population Lower costs (espec. Procedures) Fast execution Focus on science & education Lack of legacy systems / mindset Rapid growth High rate of change(sites / personnel / CRO’s / newco’s / regulations) 11

  12. (3) Maximise Market Access returns Large population Lower costs (espec. Procedures) Fast execution Focus on science & education Lack of legacy systems / mindset Rapid growth High rate of change(sites / personnel / CRO’s / newco’s / regulations) 12

  13. Where are the best centres for oncology? KOREA‘R’ as well as ‘D’ CHINAToughest, but biggest market access upside TAIWAN-long pedigree in Oncology INDIA Great metricsGreat innovation PHILIPPINES- consistent performer SINGAPORE - fast to start, predictable regulatory, Ph1 & Translational

  14. What is the role of outsourcing? Tactical Local CRO Do it yourself CRO do it all Global CRO Strategic 14

  15. Summary Asia is already a key region for Oncology DD Asia is different- Think strategic +ve not operational –ve Open mind on what / how / how much / where to outsource and maximise the CRO’s added value